Advertisement
New Zealand markets close in 3 hours 28 minutes
  • NZX 50

    11,779.67
    -41.11 (-0.35%)
     
  • NZD/USD

    0.6015
    +0.0004 (+0.06%)
     
  • NZD/EUR

    0.5585
    +0.0007 (+0.12%)
     
  • ALL ORDS

    7,993.30
    +41.00 (+0.52%)
     
  • ASX 200

    7,720.10
    +37.70 (+0.49%)
     
  • OIL

    78.80
    +0.32 (+0.41%)
     
  • GOLD

    2,335.00
    +3.80 (+0.16%)
     
  • NASDAQ

    18,093.57
    +202.77 (+1.13%)
     
  • FTSE

    8,213.49
    +41.34 (+0.51%)
     
  • Dow Jones

    38,852.27
    +176.59 (+0.46%)
     
  • DAX

    18,175.21
    +173.61 (+0.96%)
     
  • Hang Seng

    18,578.30
    0.00 (0.00%)
     
  • NIKKEI 225

    38,591.05
    +354.98 (+0.93%)
     
  • NZD/JPY

    92.7580
    +0.2880 (+0.31%)
     

Novanta to Present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024

BEDFORD, Mass., April 19, 2024--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024, in Chicago, IL.

About Novanta

Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary technology expertise and competencies in precision medicine and manufacturing, medical solutions, and robotics and automation with a proven ability to solve complex technical challenges. This enables Novanta to engineer core components and sub-systems that deliver extreme precision and performance, tailored to our customers' demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation and customer success. Novanta’s common shares are quoted on Nasdaq under the ticker symbol "NOVT."

More information about Novanta is available on the Company’s website at www.novanta.com. For additional information, please contact Novanta Inc. Investor Relations at (781) 266-5137 or InvestorRelations@novanta.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240419255779/en/

Contacts

Novanta Inc.
Investor Relations Contact:
Ray Nash
(781) 266-5137